Hepatocellular adenoma classification

Hepatocellular adenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatocellular adenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular adenoma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular adenoma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular adenoma classification
CDC on Hepatocellular adenoma classification
Hepatocellular adenoma classification in the news
Blogs on Hepatocellular adenoma classification
Directions to Hospitals Treating Hepatocellular adenoma
Risk calculators and risk factors for Hepatocellular adenoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Classification

Hepatocellular adenoma may be classified into four subtypes based on rate of occurence.

• Inflammatory hepatic adenoma: most common, highest rate of bleed
• HNF 1alpha mutated hepatic adenoma: second most common, multiple
• Beta catenin-mutated hepatic adenoma: least common, men on anabolic steroids, glycogen storage disease, familial adenomatous poliposis
• Unclassified hepatocellular adenoma

References

Template:WikiDoc Sources